Pycnangloside - Compound Card

Pycnangloside

Select a section from the left sidebar

Pycnangloside

Structure
Zoomed Structure
  • Family: Plantae - Myristicaceae
  • Kingdom: Plantae
  • Class: Peptide
Canonical Smiles CCCCCCCCCCCCCCCCC(C(=O)NC(C(C(CCCCCCC/C=C/CCCCCCC)O)O)COC1OC(CO)C(C(C1O)O)O)O
InChI InChI=1S/C44H85NO10/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-36(47)39(49)35(34-54-44-42(52)41(51)40(50)38(33-46)55-44)45-43(53)37(48)32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h15,17,35-42,44,46-52H,3-14,16,18-34H2,1-2H3,(H,45,53)/b17-15+
InChIKey JSGXQERXFGZPDI-BMRADRMJSA-N
Formula C44H85NO10
HBA 10
HBD 8
MW 788.16
Rotatable Bonds 37
TPSA 189.17
LogP 6.89
Number Rings 1
Number Aromatic Rings 0
Heavy Atom Count 55
Formal Charge 0
Fraction CSP3 0.93
Exact Mass 787.62
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Pycnanthus anglonensis Myristicaceae Plantae 224864

Showing of synonyms

  • Tsaassi V, Hussain H, et al. (2010). Pycnangloside: A New Cerebroside from Bark of Pycnanthus Angolensis. Natural Product Communications, 2010, 5(11), 1795-1798. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 788.16 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.84
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
4.98
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
1410.08

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.15
Plasma Protein Binding
35.27
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
-0.37
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Safe
Bioconcentration Factor
-34.2
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.16
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
6.6
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-2562190.84
Rat (Acute)
2.42
Rat (Chronic Oral)
4.21
Fathead Minnow
3243.07
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
285289.33
Hydration Free Energy
-2.92
Log(D) at pH=7.4
4.24
Log(P)
11.25
Log S
-5.06
Log(Vapor Pressure)
-9293.34
Melting Point
77.59
pKa Acid
-29.04
pKa Basic
7.55
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Aldos-2-ulose dehydratase P84193 AUD_PHACH Phanerodontia chrysosporium 3 0.7919

Download SDF